The options were close to expired and Irit Arbel disposed stocks. Currently, Brainstorm Cell Therapeutics has an average volume of 89.25K. The company has a one-year high of $4.50 and a one-year low …

More A Director at Brainstorm Cell Therapeutics is Exercising Options Videos